本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Apellis Pharmaceuticals Inc.

25.40
+0.75003.04%
盤後25.450.0500+0.20%19:42 EST
成交量:358.12萬
成交額:9,117.98萬
市值:32.14億
市盈率:70.92
高:26.12
開:24.67
低:24.40
收:24.65
52周最高:35.57
52周最低:16.10
股本:1.27億
流通股本:7,811.99萬
量比:1.15
換手率:4.58%
股息:- -
股息率:- -
每股收益(TTM):0.3581
每股收益(LYR):-1.5970
淨資產收益率:14.10%
總資產收益率:5.13%
市淨率:8.01
市盈率(LYR):-15.90

資料載入中...

2025/12/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/10/30

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/10/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/10/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/07/31

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/07/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/07/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/07/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/07/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/07/01

重要事件披露

Form 8-K - Current report